United States · FDA National Drug Code directory
Cephalexin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-754_1bb09c78-f794-4b3b-e063-6394a90a8936
- Product NDC
- 76420-754
- Form
- CAPSULE
- Composition / generic term
- Cephalexin
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190819
- Source listing expiry
- 20261231
Source-listed ingredients
- CEPHALEXIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 CAPSULE in 1 BOTTLE, PLASTIC (76420-754-28) · 76420-754-28
- 30 CAPSULE in 1 BOTTLE, PLASTIC (76420-754-30) · 76420-754-30
- 40 CAPSULE in 1 BOTTLE, PLASTIC (76420-754-40) · 76420-754-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →